...
首页> 外文期刊>The Journal of Clinical Investigation: The Official Journal of the American Society for Clinical Investigation >p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease
【24h】

p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease

机译:p53/microRNA-214/ULK1 轴损害糖尿病肾病患者的肾小管自噬

获取原文
获取原文并翻译 | 示例

摘要

Dysregulation of autophagy in diabetic kidney disease (DKD) has been reported, but the underlying mechanism and its pathogenic role remain elusive, We show that autophagy was inhibited in DKD models and in human diabetic kidneys. Ablation of autophagy-related gene 7 (Atg7) from kidney proximal tubules led to autophagy deficiency and worse renal hypertrophy, tubular damage, inflammation, fibrosis, and albuminuria in diabetic mice, indicating a protective role of autophagy in DKD. Autophagy impairment in DKD was associated with the downregulation of unc-51-like autophagyactivating kinase 1 (ULK1), which was mediated by the upregulation of microRNA-214 (miR-214) in diabetic kidney cells and tissues. Ablation of miR-214 from kidney proximal tubules prevented a decrease in ULK1 expression and autophagy impairment in diabetic kidneys, resulting in less renal hypertrophy and albuminuria. Furthermore, blockade of p53 attenuated miR-214 induction in DKD, leading to higher levels of ULK1 and autophagy, accompanied by an amelioration of DKD. Compared with nondiabetic samples, renal biopsies from patients with diabetes showed induction of p53 and miR-214, associated with downregulation of ULK1 and autophagy. We found a positive correlation between p53/miR-214 and renal fibrosis, but a negative correlation between ULK1/LC3 and renal fibrosis in patients with diabetes. Together, these results identify the p53/miR-214/ULK1 axis in autophagy impairment in diabetic kidneys, pinpointing possible therapeutic targets for DKD.
机译:糖尿病肾病 (DKD) 中自噬失调已有报道,但其潜在机制及其致病作用仍然难以捉摸,我们表明自噬在 DKD 模型和人类糖尿病肾脏中受到抑制。肾近端肾小管自噬相关基因7(Atg7)消融导致糖尿病小鼠自噬缺乏和肾肥大、肾小管损伤、炎症、纤维化和白蛋白尿加重,表明自噬在DKD中具有保护作用。DKD 自噬损伤与 unc-51 样自噬激活激酶 1 (ULK1) 的下调有关,ULK1 由糖尿病肾细胞和组织中 microRNA-214 (miR-214) 的上调介导。从肾近端肾小管消融 miR-214 可防止糖尿病肾中 ULK1 表达降低和自噬损伤,从而减少肾肥大和白蛋白尿。此外,阻断 p53 减弱了 DKD 中 miR-214 的诱导,导致更高水平的 ULK1 和自噬,并伴有 DKD 的改善。与非糖尿病样本相比,糖尿病患者的肾活检显示 p53 和 miR-214 的诱导,与 ULK1 和自噬的下调有关。我们发现 p53/miR-214 与糖尿病患者肾纤维化呈正相关,但 ULK1/LC3 与肾纤维化呈负相关。总之,这些结果确定了糖尿病肾脏自噬损伤中的p53/miR-214/ULK1轴,确定了DKD的可能治疗靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号